373 related articles for article (PubMed ID: 36139638)
1. The Role of the Microbiome in Pancreatic Cancer.
Miyabayashi K; Ijichi H; Fujishiro M
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139638
[TBL] [Abstract][Full Text] [Related]
2. Chronic inflammatory changes and oxidative stress in the background of "pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm".
Matsuda R; Miyasaka Y; Yamada Y; Kawata J; Sakihama K; Yamamoto T; Saeki K; Yamamoto H; Ohishi Y; Koga Y; Nakamura M; Oda Y
Virchows Arch; 2020 Dec; 477(6):799-806. PubMed ID: 32468246
[TBL] [Abstract][Full Text] [Related]
3. Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN.
Kang MJ; Lee KB; Jang JY; Kwon W; Park JW; Chang YR; Kim SW
Pancreas; 2013 Nov; 42(8):1267-74. PubMed ID: 24308063
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Analysis of Molecular Biologic Characteristics of Pancreatic Ductal Adenocarcinoma Concomitant with Intraductal Papillary Mucinous Neoplasm.
Tsujimae M; Masuda A; Ikegawa T; Tanaka T; Inoue J; Toyama H; Sofue K; Uemura H; Kohashi S; Inomata N; Nagao K; Masuda S; Abe S; Gonda M; Yamakawa K; Ashina S; Yamada Y; Tanaka S; Nakano R; Sakai A; Kobayashi T; Shiomi H; Kanzawa M; Itoh T; Fukumoto T; Ueda Y; Kodama Y
Ann Surg Oncol; 2022 Aug; 29(8):4924-4934. PubMed ID: 35606470
[TBL] [Abstract][Full Text] [Related]
5. Advances in Pancreatic Ductal Adenocarcinoma Treatment.
Anderson EM; Thomassian S; Gong J; Hendifar A; Osipov A
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771675
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of SOX9 expression in pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasm.
Tanaka T; Kuroki T; Adachi T; Ono S; Hirabaru M; Soyama A; Kitasato A; Takatsuki M; Hayashi T; Eguchi S
Pancreas; 2013 Apr; 42(3):488-93. PubMed ID: 23146920
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic cancer screening in patients with presumed branch-duct intraductal papillary mucinous neoplasms.
Torisu Y; Takakura K; Kinoshita Y; Tomita Y; Nakano M; Saruta M
World J Clin Oncol; 2019 Feb; 10(2):67-74. PubMed ID: 30815373
[TBL] [Abstract][Full Text] [Related]
8. MSX2 in pancreatic tumor development and its clinical application for the diagnosis of pancreatic ductal adenocarcinoma.
Satoh K; Hamada S; Shimosegawa T
Front Physiol; 2012; 3():430. PubMed ID: 23162473
[TBL] [Abstract][Full Text] [Related]
9. Tumor Microenvironment in Pancreatic Intraepithelial Neoplasia.
Opitz FV; Haeberle L; Daum A; Esposito I
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944807
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of para-aortic lymph node status in resected pancreatic ductal adenocarcinoma and invasive intraductal papillary mucinous neoplasm - Time to consider a reclassification?
Linder S; Holmberg M; Engstrand J; Ghorbani P; Sparrelid E
Surg Oncol; 2022 May; 41():101735. PubMed ID: 35287096
[TBL] [Abstract][Full Text] [Related]
11. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma.
Qian Y; Gong Y; Fan Z; Luo G; Huang Q; Deng S; Cheng H; Jin K; Ni Q; Yu X; Liu C
J Hematol Oncol; 2020 Oct; 13(1):130. PubMed ID: 33008426
[TBL] [Abstract][Full Text] [Related]
12. Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma.
Fan JQ; Wang MF; Chen HL; Shang D; Das JK; Song J
Mol Cancer; 2020 Feb; 19(1):32. PubMed ID: 32061257
[TBL] [Abstract][Full Text] [Related]
13. Deep sequencing of cancer-related genes revealed GNAS mutations to be associated with intraductal papillary mucinous neoplasms and its main pancreatic duct dilation.
Takano S; Fukasawa M; Maekawa S; Kadokura M; Miura M; Shindo H; Takahashi E; Sato T; Enomoto N
PLoS One; 2014; 9(6):e98718. PubMed ID: 24897499
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs Deregulated in Intraductal Papillary Mucinous Neoplasm Converge on Actin Cytoskeleton-Related Pathways That Are Maintained in Pancreatic Ductal Adenocarcinoma.
Fernandez-Castañer E; Vila-Casadesus M; Vila-Navarro E; Parra C; Lozano JJ; Castells A; Gironella M
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34069007
[TBL] [Abstract][Full Text] [Related]
15. Concomitant Intraductal Papillary Mucinous Neoplasm in Pancreatic Ductal Adenocarcinoma Is an Independent Predictive Factor for the Occurrence of New Cancer in the Remnant Pancreas.
Matsuda R; Miyasaka Y; Ohishi Y; Yamamoto T; Saeki K; Mochidome N; Abe A; Ozono K; Shindo K; Ohtsuka T; Kikutake C; Nakamura M; Oda Y
Ann Surg; 2020 May; 271(5):941-948. PubMed ID: 30308608
[TBL] [Abstract][Full Text] [Related]
16. The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications.
Liu X; Xu J; Zhang B; Liu J; Liang C; Meng Q; Hua J; Yu X; Shi S
Mol Cancer; 2019 Dec; 18(1):184. PubMed ID: 31831007
[TBL] [Abstract][Full Text] [Related]
17. The Emerging Role of Microbiota and Microbiome in Pancreatic Ductal Adenocarcinoma.
Ciernikova S; Novisedlakova M; Cholujova D; Stevurkova V; Mego M
Biomedicines; 2020 Dec; 8(12):. PubMed ID: 33287196
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic Adenocarcinoma Associated to Intraductal Papillary Mucinous Neoplasia: Histopathological Particularities and Clinical Implications.
Schlanger D; Popa C; Rusu I; Hajjar NA
Chirurgia (Bucur); 2022 Jun; 117(4):454-462. PubMed ID: 36049103
[No Abstract] [Full Text] [Related]
19. Nanoparticle-Based Therapeutic Strategies for Enhanced Pancreatic Ductal Adenocarcinoma Immunotherapy.
Hou W; Yang B; Zhu H
Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297467
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm: a report of 8 cases.
Mandai K; Uno K; Yasuda K
Clin J Gastroenterol; 2013 Jun; 6(3):248-54. PubMed ID: 26181604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
